https://doi.org/10.1016/j.semarthrit.2024.152388
S
Sara Nysom Christiansen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
59
Papers
498
Citations
13
h-index
14
i10-index
Sara Nysom Christiansen is an academic researcher from Glostrup Hospital. The author has contributed to research in topics: Spondyloarthritis Studies and Treatments & Gout, Hyperuricemia, Uric Acid & Rheumatoid Arthritis Research and Therapies. The author has an h-index of 13, co-authored 51 publications.
ORCID: 0000-0002-5063-9932Papers by this author
worksPatient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice
2024 · Seminars in Arthritis and Rheumatism · 8 citations
Core domain set for studies of acute calcium pyrophosphate crystal arthritis: OMERACT delphi survey to establish consensus
2025 · Seminars in Arthritis and Rheumatism · 1 citations
https://doi.org/10.1016/j.semarthrit.2025.152670
OP0183 PREDICTORS OF SECUKINUMAB TREATMENT RESPONSE AND CONTINUATION IN AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE EUROSPA RESEARCH COLLABORATION NETWORK
2024 · Annals of the Rheumatic Diseases · 0 citations
https://doi.org/10.1136/annrheumdis-2024-eular.562
POS0954 THE IMPACT OF SMOKING STATUS ON ONE-YEAR SECUKINUMAB RETENTION RATE IN 1,684 PATIENTS WITH PSORIATIC ARTHRITIS: REAL-WORLD RESULTS FROM THE EUROSPA COLLABORATION
2024 · Annals of the Rheumatic Diseases · 0 citations
https://doi.org/10.1136/annrheumdis-2024-eular.344
Construct validity and responsiveness of ASAS Health Index assessed in two longitudinal studies of tumour necrosis factor alpha inhibitor initiation and dose reduction in patients with axial spondyloarthritis
2024 · RMD Open · 0 citations
https://doi.org/10.1136/rmdopen-2024-004948
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat